• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immunity . A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination

tetano

Editor, Senior Moderator
Immunity


. 2023 Mar 16;S1074-7613(23)00094-8.
doi: 10.1016/j.immuni.2023.03.001. Online ahead of print.
A transcriptionally distinct subset of influenza-specific effector memory B cells predicts long-lived antibody responses to vaccination in humans


Anoma Nellore[SUP] 1 [/SUP], Esther Zumaquero[SUP] 2 [/SUP], Christopher D Scharer[SUP] 3 [/SUP], Christopher F Fucile[SUP] 4 [/SUP], Christopher M Tipton[SUP] 5 [/SUP], R Glenn King[SUP] 2 [/SUP], Tian Mi[SUP] 3 [/SUP], Betty Mousseau[SUP] 2 [/SUP], John E Bradley[SUP] 6 [/SUP], Fen Zhou[SUP] 2 [/SUP], Stuti Mutneja[SUP] 7 [/SUP], Paul A Goepfert[SUP] 8 [/SUP], Jeremy M Boss[SUP] 3 [/SUP], Troy D Randall[SUP] 6 [/SUP], Ignacio Sanz[SUP] 5 [/SUP], Alexander F Rosenberg[SUP] 9 [/SUP], Frances E Lund[SUP] 10 [/SUP]



Affiliations

Abstract

Seasonal influenza vaccination elicits hemagglutinin (HA)-specific memory B (Bmem) cells, and although multiple Bmem cell populations have been characterized, considerable heterogeneity exists. We found that HA-specific human Bmem cells differed in the expression of surface marker FcRL5 and transcriptional factor T-bet. FcRL5[SUP]+[/SUP]T-bet[SUP]+[/SUP] Bmem cells were transcriptionally similar to effector-like memory cells, while T-bet[SUP]neg[/SUP]FcRL5[SUP]neg[/SUP] Bmem cells exhibited stem-like central memory properties. FcRL5[SUP]+[/SUP] Bmem cells did not express plasma-cell-commitment factors but did express transcriptional, epigenetic, metabolic, and functional programs that poised these cells for antibody production. Accordingly, HA[SUP]+[/SUP] T-bet[SUP]+[/SUP] Bmem cells at day 7 post-vaccination expressed intracellular immunoglobulin, and tonsil-derived FcRL5[SUP]+[/SUP] Bmem cells differentiated more rapidly into antibody-secreting cells (ASCs) in vitro. The T-bet[SUP]+[/SUP] Bmem cell response positively correlated with long-lived humoral immunity, and clonotypes from T-bet[SUP]+[/SUP] Bmem cells were represented in the secondary ASC response to repeat vaccination, suggesting that this effector-like population predicts influenza vaccine durability and recall potential.

Keywords: T-bet; durable immunity; influenza vaccination; memory B cells; plasmablasts.
 
Back
Top Bottom